Cargando…
Prediction Ability of Charlson, Elixhauser, and Rx-Risk Comorbidity Indices for Mortality in Patients with Hip Fracture. A Danish Population-Based Cohort Study from 2014 – 2018
OBJECTIVE: Comorbidity has an important role in risk prediction and risk adjustment modelling in observational studies. However, it is unknown which comorbidity index is most accurate to predict mortality in hip fracture patients. We aimed to evaluate the prediction ability, including discrimination...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8922332/ https://www.ncbi.nlm.nih.gov/pubmed/35299726 http://dx.doi.org/10.2147/CLEP.S346745 |
_version_ | 1784669502609293312 |
---|---|
author | Vesterager, Jeppe Damgren Madsen, Morten Hjelholt, Thomas Johannesson Kristensen, Pia Kjær Pedersen, Alma Becic |
author_facet | Vesterager, Jeppe Damgren Madsen, Morten Hjelholt, Thomas Johannesson Kristensen, Pia Kjær Pedersen, Alma Becic |
author_sort | Vesterager, Jeppe Damgren |
collection | PubMed |
description | OBJECTIVE: Comorbidity has an important role in risk prediction and risk adjustment modelling in observational studies. However, it is unknown which comorbidity index is most accurate to predict mortality in hip fracture patients. We aimed to evaluate the prediction ability, including discrimination and calibration of Charlson comorbidity index (CCI), Elixhauser comorbidity index (ECI) and Rx-risk index for 30 day- and 1 year mortality in a population-based cohort of hip fracture surgery patients. METHODS: Using the Danish Multidisciplinary Hip Fracture Registry in the period 2014–2018, 31,443 patients were included. CCI and ECI were based on discharge diagnoses, while Rx-Risk index was based on pharmacy dispensings. We used logistic regression to assess discrimination of the different indices, individually and in combinations, by calculating c-statistics and the contrast in c-statistic to a base model including only age and gender with 95% confidence intervals (CI). RESULTS: The study cohort were primarily female (69%) and older than 85 years (42%). The 30-day mortality was 10.1% and the 1-year mortality was 26.6%. Age and gender alone had a good discrimination ability for 30-day and 1-year mortality (c-statistic=0.70, CI: 0.69–0.71 and c-statistic=0.68, CI: 0.67 −0.69, respectively). By adding indices individually to the base model, Rx-risk index had the best 30-day and 1-year mortality discrimination ability (c-statistic=0.73, CI: 0.72–0.74 and 0.71 CI: 0.71–0.72, respectively). By adding combination of indices to the base model, a combination of CCI and the Rx-risk index had a 30-day and 1-year mortality discrimination ability of c-statistic=0.74, CI: 0.73–0.75 and c-statistic=0.73, CI: 0.73–0.74, respectively. Calibration of indices was similar. CONCLUSION: The highest discrimination ability was achieved by combining CCI and Rx-risk index in addition to age and gender. However, age and gender alone had a fair mortality discrimination ability. |
format | Online Article Text |
id | pubmed-8922332 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-89223322022-03-16 Prediction Ability of Charlson, Elixhauser, and Rx-Risk Comorbidity Indices for Mortality in Patients with Hip Fracture. A Danish Population-Based Cohort Study from 2014 – 2018 Vesterager, Jeppe Damgren Madsen, Morten Hjelholt, Thomas Johannesson Kristensen, Pia Kjær Pedersen, Alma Becic Clin Epidemiol Original Research OBJECTIVE: Comorbidity has an important role in risk prediction and risk adjustment modelling in observational studies. However, it is unknown which comorbidity index is most accurate to predict mortality in hip fracture patients. We aimed to evaluate the prediction ability, including discrimination and calibration of Charlson comorbidity index (CCI), Elixhauser comorbidity index (ECI) and Rx-risk index for 30 day- and 1 year mortality in a population-based cohort of hip fracture surgery patients. METHODS: Using the Danish Multidisciplinary Hip Fracture Registry in the period 2014–2018, 31,443 patients were included. CCI and ECI were based on discharge diagnoses, while Rx-Risk index was based on pharmacy dispensings. We used logistic regression to assess discrimination of the different indices, individually and in combinations, by calculating c-statistics and the contrast in c-statistic to a base model including only age and gender with 95% confidence intervals (CI). RESULTS: The study cohort were primarily female (69%) and older than 85 years (42%). The 30-day mortality was 10.1% and the 1-year mortality was 26.6%. Age and gender alone had a good discrimination ability for 30-day and 1-year mortality (c-statistic=0.70, CI: 0.69–0.71 and c-statistic=0.68, CI: 0.67 −0.69, respectively). By adding indices individually to the base model, Rx-risk index had the best 30-day and 1-year mortality discrimination ability (c-statistic=0.73, CI: 0.72–0.74 and 0.71 CI: 0.71–0.72, respectively). By adding combination of indices to the base model, a combination of CCI and the Rx-risk index had a 30-day and 1-year mortality discrimination ability of c-statistic=0.74, CI: 0.73–0.75 and c-statistic=0.73, CI: 0.73–0.74, respectively. Calibration of indices was similar. CONCLUSION: The highest discrimination ability was achieved by combining CCI and Rx-risk index in addition to age and gender. However, age and gender alone had a fair mortality discrimination ability. Dove 2022-03-08 /pmc/articles/PMC8922332/ /pubmed/35299726 http://dx.doi.org/10.2147/CLEP.S346745 Text en © 2022 Vesterager et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Vesterager, Jeppe Damgren Madsen, Morten Hjelholt, Thomas Johannesson Kristensen, Pia Kjær Pedersen, Alma Becic Prediction Ability of Charlson, Elixhauser, and Rx-Risk Comorbidity Indices for Mortality in Patients with Hip Fracture. A Danish Population-Based Cohort Study from 2014 – 2018 |
title | Prediction Ability of Charlson, Elixhauser, and Rx-Risk Comorbidity Indices for Mortality in Patients with Hip Fracture. A Danish Population-Based Cohort Study from 2014 – 2018 |
title_full | Prediction Ability of Charlson, Elixhauser, and Rx-Risk Comorbidity Indices for Mortality in Patients with Hip Fracture. A Danish Population-Based Cohort Study from 2014 – 2018 |
title_fullStr | Prediction Ability of Charlson, Elixhauser, and Rx-Risk Comorbidity Indices for Mortality in Patients with Hip Fracture. A Danish Population-Based Cohort Study from 2014 – 2018 |
title_full_unstemmed | Prediction Ability of Charlson, Elixhauser, and Rx-Risk Comorbidity Indices for Mortality in Patients with Hip Fracture. A Danish Population-Based Cohort Study from 2014 – 2018 |
title_short | Prediction Ability of Charlson, Elixhauser, and Rx-Risk Comorbidity Indices for Mortality in Patients with Hip Fracture. A Danish Population-Based Cohort Study from 2014 – 2018 |
title_sort | prediction ability of charlson, elixhauser, and rx-risk comorbidity indices for mortality in patients with hip fracture. a danish population-based cohort study from 2014 – 2018 |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8922332/ https://www.ncbi.nlm.nih.gov/pubmed/35299726 http://dx.doi.org/10.2147/CLEP.S346745 |
work_keys_str_mv | AT vesteragerjeppedamgren predictionabilityofcharlsonelixhauserandrxriskcomorbidityindicesformortalityinpatientswithhipfractureadanishpopulationbasedcohortstudyfrom20142018 AT madsenmorten predictionabilityofcharlsonelixhauserandrxriskcomorbidityindicesformortalityinpatientswithhipfractureadanishpopulationbasedcohortstudyfrom20142018 AT hjelholtthomasjohannesson predictionabilityofcharlsonelixhauserandrxriskcomorbidityindicesformortalityinpatientswithhipfractureadanishpopulationbasedcohortstudyfrom20142018 AT kristensenpiakjær predictionabilityofcharlsonelixhauserandrxriskcomorbidityindicesformortalityinpatientswithhipfractureadanishpopulationbasedcohortstudyfrom20142018 AT pedersenalmabecic predictionabilityofcharlsonelixhauserandrxriskcomorbidityindicesformortalityinpatientswithhipfractureadanishpopulationbasedcohortstudyfrom20142018 |